Catalyst Wire Dossier Catalyst Wire Dossier

Sanofi Pasteur TIV + H1N1

trivalent inactivated influenza vaccine (TIV) with H1N1 component · Sanofi Pasteur
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sanofi Pasteur TIV + H1N1, covering 2011-05-26 to 2011-05-26. Get the full timeline:

Most recent: Clinical Trial Update: Sanofi Pasteur, TIV + H1N1, Pediatric Population [Phase 2]

See pricing